Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $47.55 USD
Change Today -0.16 / -0.34%
Volume 322.5K
TTPH On Other Exchanges
Symbol
Exchange
Berlin
As of 8:10 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Guy MacDonald B.Sc

Chief Executive Officer, President and Director, Tetraphase Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 25 board members in 3 different organizations across 4 different industries.

See Board Relationships
56$1,961,886
As of Fiscal Year 2014

Background*

Mr. Guy Macdonald, B.Sc has been the President and Chief Executive Officer of Tetraphase Pharmaceuticals, Inc. since January 2008. Mr. Macdonald leads Tetraphase's drug discovery and development programs, capitalizing on its breakthrough synthetic chemistry platform. He is a 25-year veteran of the global pharmaceutical and biotechnology sector. He has a wealth of experience in drug development and commercialization, particularly with anti-infectives including antifungals. ...

Read Full Background

Corporate Headquarters*

480 Arsenal Street
Watertown, Massachusetts 02472

United States

Phone: 617-715-3600
Fax: 617-926-3557

Board Members Memberships*

Director
2008-Present
Chief Executive Officer, President and Director
2014-Present
Chairman and Member of Compensation Committee

Education*

Bachelor's Degree
University Of Dundee
BS
University Of Dundee
Honors Degree
University Of Dundee

Other Affiliations*

Annual Compensation*

Salary$420,000
Total Annual Compensation$420,000

Stock Options*

All Other Compensation$5,826
Exercisable Options385,964
Unexercisable Options303,571
Total Number of Options689,535

Total Compensation*

Total Annual Cash Compensation$709,326
Total Short Term Compensation$420,000
Other Long Term Compensation$5,826
Total Calculated Compensation$1,961,886
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TTPH:US $47.55 USD -0.16

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TETRAPHASE PHARMACEUTICALS I, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.